Joseph Boyd, PhD., and Vi Chu, Ph.D., Cell Biology R&D, Life Science Business of Merck.
Organoids—complex, multicellular, 3-dimensional in vitro cell models used in biomedical research that closely mimic in vivo organs—are a powerful way to study drug responses, disease progression and more. These complex mini organs are helping to revolutionise our understanding of cancer, paving the way for personalised treatments and unlocking findings that traditional 2D cell culture models can’t reveal.